long-term effects of glp-1 drugs The revolution: What UAB researchers are discovering about how these work GLP-1 Receptor Agonists | New

Diabetes drugs in the GLP-1 agonists class include: Dulaglutide (Trulicity), taken by injection weekly Exenatide extended release (Bydureon), taken by injection weekly Exenatide (Byetta), taken by injection twice daily Semaglutide (Ozempic), taken by injection weekly Semaglutide (Rybelsus), taken by mouth once daily Liraglutide (Victoza), taken by injection daily Lixisenatide (Adlyxin), taken by injection daily These medications mimic the action of a hormone called glucagon-like peptide 1

Using Truveta Data, we sought to answer a few simple but timely questions: who is receiving the oral semaglutide pill in the first weeks following FDA approval, what provider types are prescribing these drugs, and are these patients new GLP-1-therapy initiators or patients switching from an existing prescription

Prior MR studies have addressed the causality between T2D and SA, including models adjusted for BMI [51]

Therefore, the results of our analysis were stable

Ozempic gets mentioned in many headlines, but the distinction matters